Abiraterone Plus Prednisone Effective for Metastatic Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Abiraterone Plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
N. Engl. J. Med 2017 Jun 04;[EPub Ahead of Print], K Fizazi, N Tran, L Fein, N Matsubara, A Rodriguez-Antolin, BY Alekseev, M Özgüroğlu, D Ye, S Feyerabend, A Protheroe, P De Porre, T Kheoh, YC Park, MB Todd, KN ChiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.